NAD+ metabolism in health and disease.
By Peter Belenky, Katrina L. Bogan, Charles Brenner. 2007
957 citations recorded by the source corpus.
Subfields: Geriatrics and Gerontology, Oncology, Physiology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Geriatrics and Gerontology
In Oncology
In Physiology
- Johan Auwerx
- C. Cantó
- S. Imai
- R. Houtkooper
- L. J. Castro-Muñoz
- J. Manzo-Merino
- D. O. Reyes-Hernández
- A. García-Carrancá
Citations in the corpus
- ECOD: An Evolutionary Classification of Protein Domains (2014, background): “Thus, SAM and NAD(P) share the adenosine part but differ in the other half, and the two enzyme superfamilies exploit the dissimilar parts of the cofactors to catalyze different reactions [41,42,43].”
- NAD+/NADH and NADP+/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences (2008, neutral): “Increasing evidence has suggested that the pyridine nucleotides NAD and NADP have far more extensive biological functions than their classical functions (27, 29, 233, 328, 329).”
- Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches (2019, background): “In the opposite direction, lactate is oxidized to form pyruvate, while NAD+ is reduced to NADH (63).”
- The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. (2010, background): “In the pancreas, SIRT1 regulates insulin secretion by decreasing uncoupling protein-2 expression and mitochondrial uncoupling, allowing a more efficient ATP synthesis (109, 110).”
- NAD+ intermediates: The biology and therapeutic potential of NMN and NR (2017, neutral): “2 Cell Metabolism 27, February 6, 2018 Reflecting such rapid progress in the field, there have already been a number of excellent review articles about general NAD biology and its relevance to disease (Belenky et al., 2007; Canto et al., 2015; Chini et al., 2016; Fang et al., 2017; Imai and Guarente”
- Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (2007, background): “In prokaryotes and lower eukaryotes, such as yeast, NAD is synthesized by the de novo pathway via quinolinic acid and by the salvage pathway via nicotinic acid (Belenky et al., 2007; Revollo et al., 2007; Rongvaux et al., 2003) (see Figure S1A in the Supplemental Data available with this article onl”
- Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes (2015, background): “…phosphorylated derivatives (NADH, NADP, and NADPH) have many functions in cells, such as serving as hydride donors and acceptors in redox reactions (Belenky et al., 2007; Houtkooper et al., 2010), participation in bacterial and DNA ligase reactions (Wilkinson et al., 2001), and roles as molecules…”